Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size, Status and Forecast 2022
- QYR2349598
- 98 Pages
- January 2018
- Medical Devices
Astellas Pharma
Johnson & Johnson
Sanofi
Valeant
Dendreon
Bayer
...
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiotherapy
Market segment by Application, Castration-Resistant Prostate Cancer (CRPC) Treatment can be split into
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size, Status and Forecast 2022
1 Industry Overview of Castration-Resistant Prostate Cancer (CRPC) Treatment
1.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Overview
1.1.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Castration-Resistant Prostate Cancer (CRPC) Treatment Market by Type
1.3.1 Chemotherapy
1.3.2 Hormonal Therapy
1.3.3 Immunotherapy
1.3.4 Radiotherapy
1.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Others
2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Competition Analysis by Players
2.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Astellas Pharma
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Sanofi
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Valeant
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Dendreon
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bayer
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) (2012-2017)
3.6.5 Recent Developments
4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size by Type and Application (2012-2017)
4.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size by Type (2012-2017)
4.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Castration-Resistant Prostate Cancer (CRPC) Treatment in Future
4.4 Top Consumer/End Users of Castration-Resistant Prostate Cancer (CRPC) Treatment
5 United States Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
5.1 United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
5.2 United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
6 EU Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
6.1 EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
6.2 EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
7 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
7.1 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
7.2 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
8 China Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
8.1 China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
8.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
9 India Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
9.1 India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
9.2 India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Development Status and Outlook
10.1 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (2012-2017)
10.2 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Value) by Regions (2017-2022)
11.1.1 United States Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.1.2 EU Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.1.3 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.1.4 China Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.1.5 India Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate (2017-2022)
11.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Value) by Type (2017-2022)
11.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size by Application (2017-2022)
12 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Dynamics
12.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Opportunities
12.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Product Scope
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share by Regions in 2016
Figure United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share by Type in 2016
Figure Chemotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Hormonal Therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Radiotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Others
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2016 and 2017)
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Table Astellas Pharma Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Dendreon Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Dendreon (2012-2017)
Figure Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Business Revenue Market Share in 2016
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Type (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2012
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2013
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2014
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2015
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2016
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2017
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2012
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2013
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2014
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2015
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2016
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Castration-Resistant Prostate Cancer (CRPC) Treatment
Figure United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure United States Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure EU Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2016
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Players in 2017
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Regions (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Regions (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Regions in 2017
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Regions in 2022
Figure United States Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Type (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2017
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size Share by Type in 2022
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2017
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
